"Our experimental drug can protect against all forms of Ebola known to harm people, suggesting that it will continue to protect people if the Ebola viruses evolve over time," Thomas Geisbert, Professor at The University of Texas.
After developing an effective vaccine for the deadly Ebola virus, Texas scientists are now claiming promising results with a new medication to better treat full-blown cases of the disease. In a laboratory study published this week, researchers at the University of Texas Medical Branch at Galveston showed a single injection of two antibodies successfully treated monkeys infected with all strains of the virus, a significant advance on current treatment options which only cover one strain and require multiple injections.
"This medication would give doctors an advantage in situations where we don't know which strain of Ebola is going to pop up next," Thomas Geisbert said. He further said that the study results, published Wednesday in Cell Host & Microbe, suggest the medication would be effective even if Ebola viruses evolve over time. Whereas, Larry Zeitlin, president of Mapp Biopharmaceutical Inc., the drug manufacturer, said it should "reduce the burden on health-care workers in the field during outbreaks."